ICL Israel Chemicals Ltd

Basic Materials · Agricultural Inputs

5.00$ +1.4% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

ICL Israel Chemicals Ltd (ICL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 2,135 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ICL
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	1,383	1,338	1,295	1,322	1,440	1,361	1,404	1,371	1,371	1,410	1,415	1,425	1,325	1,106	1,319	1,203	1,204	1,317	1,510	1,617	1,790	2,038	2,525	2,880	2,519	2,091	2,098	1,868	1,862	1,690	1,735	1,752	1,753	1,601	1,767	1,832	1,853	1,701	2,023	2,135	7,712
Cost of Revenue	922	922	937	907	970	932	973	913	913	903	914	917	853	770	919	883	839	912	1,015	1,047	1,101	1,181	1,280	1,341	1,204	1,158	1,270	1,189	1,276	1,130	1,178	1,184	1,157	1,066	1,207	1,278	1,249	1,233	1,397	1,471	5,350
Gross Profit	461	416	358	415	470	429	431	458	458	507	501	508	472	336	400	320	365	405	495	570	689	857	1,245	1,539	1,315	933	828	679	586	560	557	568	596	535	560	554	604	468	626	664	2,362
Research & Development	18	19	15	13	12	15	14	15	13	13	13	12	13	12	14	10	13	17	15	14	16	19	18	17	18	15	18	19	17	17	17	14	19	19	18	19	16	17	15	14	62
Selling, General & Administrative	80	80	66	65	60	70	70	62	63	62	63	65	62	706	64	56	55	57	62	67	69	979	69	74	70	78	68	55	66	247	64	64	63	68	77	72	77	73	77	78	305
Total Operating Expenses	792	344	242	271	290	240	-554	286	262	341	274	268	271	248	268	489	265	266	310	327	368	396	343	400	380	393	363	379	359	411	354	357	382	388	375	365	374	369	391	397	1,531
Operating Income	-331	72	116	144	180	189	985	172	196	166	227	240	201	88	132	-169	100	139	185	243	321	461	902	1,139	935	540	465	300	227	149	203	211	214	147	185	189	230	99	235	267	831
Interest Expense	80	4.0	91	82	61	84	40	76	42	14	79	49	67	25	73	54	52	123	60	64	54	100	67	138	57	65	87	89	79	4.0	60	59	46	16	62	98	45	93	61	132	331
Pre-Tax Income	-369	55	103	96	144	162	971	118	172	103	192	204	169	63	81	-199	71	93	165	213	287	423	868	1,125	911	499	421	251	185	117	168	178	176	114	148	168	186	-61	193	224	542
Income Tax Expense	-22	50	42	41	62	13	45	20	45	19	51	46	35	15	20	-33	14	24	23	64	45	128	211	540	276	158	127	84	43	33	42	48	49	33	42	60	57	2.0	53	72	184
Net Income	-340	32	68	57	84	155	928	101	129	82	139	158	130	48	60	-168	54	65	135	140	225	283	632	563	633	331	280	163	137	67	109	115	113	70	91	93	115	-73	126	137	305
EBITDA	-176	179	210	239	341	353	1,082	299	290	296	338	362	311	90	272	-26	205	345	342	402	464	546	1,057	1,377	1,083	511	635	481	383	168	375	389	362	213	361	416	343	198	395	523	1,459

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings